arrow
A

Alessandro Busca

s.s. trapianto di cellule staminali
H指数:48
被引数:9,863

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: a study from the ALWP/EBMT

更正:与含移植后环磷酰胺的错配无关供者异基因移植相比,T细胞充足型半相合移植在二次急性髓系白血病首次完全缓解患者中的研究:ALWP/EBMT研究

2026-11-050
OAAI
Real-Life Study on Gilteritinib-Related Infections (GilteRInf): An Italian SEIFEM Study

Gilteritinib相关感染的Real-Life研究(GilteRInf):一项意大利SEIFEM研究

2026-07-280
OAAI
T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT

T细胞富集的半相合移植与使用移植后环磷酰胺的错配无关供者异基因移植治疗首次完全缓解期继发性急性髓系白血病患者的比较:一项来自ALWP/EBMT的研究

2026-06-270
OAAI
Risk Stratification for Late-Onset CMV Infection Following Prophylaxis With Letermovir in Allogeneic Stem Cell Transplant Recipients: Unraveling the Potential Role of CMV-Specific Cell-Mediated Immunity

异基因造血干细胞移植受者接受莱特莫韦预防后晚期巨细胞病毒(CMV)感染的危险分层:阐明CMV特异性细胞介导免疫的潜在作用

2026-06-100
PRE
Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMT

混合表型急性白血病患者接受异基因造血干细胞移植的结局:EBMT ALWP的回顾性研究

2026-05-270
PRE
Characteristics and Outcomes of Progressive Multifocal Leukoencephalopathy in Hematologic Malignancies: A SEIFEM Retrospective Review

进展性多灶性白质脑症在血液系统恶性肿瘤中的特征与结局:一项SEIFEM回顾性研究

2026-03-270
OAAI
Peripheral blood stem cells versus bone marrow graft for non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT

外周血干细胞与骨髓移植物在含移植后环磷酰胺的非T细胞去除半相合移植治疗二次急性髓系白血病首次完全缓解患者中的比较:一项来自ALWP/EBMT的研究

2026-03-250
OAAI
Unrelated donor transplantation for relapsed refractory aplastic anemia, with quadruple GvHD prophylaxis

无关供者移植治疗复发难治性再生障碍性贫血,联合四联GvHD预防

2025-12-020
PRE
Non-T-Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP/EBMT

与来自相合同胞或无关供者的异基因移植相比,非T细胞耗竭的半相合移植在二次急性髓系白血病首次完全缓解期患者中的应用:一项来自ALWP/EBMT的研究

2025-12-010
OAAI
Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA Registry
2025-12-010
OAAI
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study

移植物抗宿主病流行病学、预防和管理趋势:意大利骨髓移植、造血干细胞和细胞治疗小组(GITMO)GVHD24研究

2025-11-010
PRE
Venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogeneic HSCT

维奈克拉 plus 低甲基化药物作为异基因HSCT后复发的髓系恶性肿瘤的首次挽救性治疗

2025-10-210
PRE
Post-transplantation cyclophosphamide and antithymocyte globulin in 8/10 HLA-mismatched unrelated donor transplantation: the analysis on behalf of the transplant complications working party of the EBMT

移植后环磷酰胺和抗胸腺细胞球蛋白在8/10 HLA错配无关供者移植中的应用:欧洲血液和骨髓移植学会移植并发症工作组的分析

2025-08-190
PRE
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report
2024-12-230
OAAI